ABOUT THE COMPANY

Geneyx - The Whole Genome Company

When it comes to the analysis and interpretation of the sequenced whole human genome – Geneyx Analysis, our AI-based platform, is the first and best choice for hospitals, genetic labs, translational and early target discovery researchers at Pharma. Powered by the comprehensive and popular GeneCards Knowledgebase Suite, it provides clinicians with accurate and rapid diagnoses with double the diagnostic yield, while reducing turn-around time to minutes.

Geneyx’s technology provides biomedical interpretation capabilities for more than 18% of the genome (more than 10x the protein-coding scope), and continually provide new solutions for enhancing this scope. This enables researchers to better leverage the power of whole genome sequencing data and distill novel findings that will lead to the development of the next generation of targeted and personalized therapeutics and diagnostics.

Much of the genetic data generated today is silo’d in hospitals around the world, and can be better used by researchers in targeted therapeutic development. Geneyx’s platform provides hospitals with better diagnostics, and the opportunity to support the development of these novel therapeutics that will offer better care for their patients.

TEAM

Management Team

David Yizhar
David Yizhar
Co-founder and Chief Executive Officer
Dvir Dahary
Dvir Dahary
Co-founder and Chief Scientific Officer
Asaf Porat
Asaf Porat
Chief Financial Officer
Raviv Itzhaky
Raviv Itzhaky
Co-founder and Chief Marketing Officer
Avi Yitzhak
Avi Yitzhak
Co-founder and Chief Technology Officer
Yaron Mazor
Yaron Mazor
Vice President of R&D
Ofer Barnea PhD.
Ofer Barnea PhD.
Co-Founder

Contact Us

Request A Demo